Form D · Venture Capital Fund
HB-WIN 2024 VQ Biomedical Series, a series of HB-WIN LLC
Cary, NC · CIK 0002050196
Offering snapshot reported Dec 27, 2024 · SEC filing
- Reported sold
- $555K Offering amount: $610K
- Investors reported
- 36 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Oct 22, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 27, 2024 | Initial | $555,250 | No comparison | 36 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-533527
Source: Form D, filed Dec 27, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Michael Harlow | Director |
| John Powell Leachman | Director, Promoter |
| Robert Earl Ross | Director, Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
107 Kilmayne Drive Suite B
Cary, NC, 27511
Cary, NC, 27511